𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells

✍ Scribed by Tian-nian Ren; Jing-song Wang; Yun-mian He; Chang-liang Xu; Shu-zhen Wang; Tao Xi

Publisher
Springer US
Year
2010
Tongue
English
Weight
549 KB
Volume
28
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novobiocin decreases SMYD3 expression an
Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells
✍ Xue-Gang Luo; Jia-Ning Zou; Shu-Zhen Wang; Tong-Cun Zhang; Tao Xi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

## Abstract SET and MYND domain‐containing protein 3 (SMYD3) is a histone methyltransferase that plays an important role in transcriptional regulation in human carcinogenesis, and heat‐shock protein HSP90A has been shown to increase the activity of SMYD3. We previously reported that overexpression

Peroxisome proliferator–activated recept
Peroxisome proliferator–activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231
✍ Kate M. Suchanek; Fiona J. May; Jodie A. Robinson; Won Jae Lee; Nicola A. Holman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract Peroxisome proliferator–activated receptor (PPAR) α is a ligand‐activated transcription factor that has been linked with rodent hepatocarcinogenesis. It has been suggested that __PPARα__ mRNA expression levels are an important determinant of rodent hepatic tumorigenicity. Previous work